Popular

Natural Therapeutics pioneer Herborium Group, Inc. (OTC - HBRM) is enjoying the convergence of underlying industry product demand, its proprietary products for new, widespread conditions, a big presence in Asia, and the benefit of broad, new initiatives.

With its primary Pet CBD market growing 40% annually, Link Reservations, Inc. (OTC - LRSV) is set to generate meaningful share of key CBD markets in the US and Europe.

Electromedical Technologies Inc. (OTCQB - EMED) has executed key funding to advance its new product for potentially major sales growth next year.

Sigyn Therapeutics, Inc. (OTC - SIGY) could change the way we treat sepsis, the #1 cause of death in hospitals, as well as COVID-19.

Restaurant.com Parent RDE Inc. (OTCQB: RSTN) went from $2 to $4.48 in just 2 weeks for us before trending back. See why we think it can double again.

Mitesco, Inc.'s (OTCQB - MITI) flagship subsidiary is launching the first location---today---of a novel new clinic that should generate more recurring sales and profit than its peers.

As an early-stage biotech, each milestone event typically leads to higher prices. QSAM Biosciences, Inc. (OTCQB - QSAM) just raised $2.5M and is soon to commence a Phase I trial.

Home Bistro, Inc. (OTC - HBIS) is a pure play gourmet meal delivery firm enjoying outsized growth and could emerge as one of the stars of the multi-billion-dollar industry, aided by its relationship with Iron Chef Cat Cora.